AddLife AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AddLife AB with three other
miscellaneous service companies in Europe:
sales of 530.26 million Euros [US$629.76 million]
of UNITED KINGDOM
(£551.40 million [US$757.42 million]
of which 54%
was Operating Genus PIC), and
GW Pharmaceuticals PLC
based in UNITED KINGDOM
(£407.91 million [US$560.32 million]
of which 100%
was Novel Therapeutics).
AddLife AB reported sales of SEK 5.27 billion (US$611.12 million)
December of 2020.
increase of 51.6%
versus 2019, when the company's sales were SEK 3.48 billion.
Sales at AddLife AB have increased during each of the previous five years
(and since 2015, sales have increased a total of 399%).
Sales of Labtech saw an increase
62.1% in 2020, from
SEK 1.98 billion to SEK 3.21 billion.